title: [Olanzapine pamoate injection -- experience and case reports from Hungarian clinical practice].
abstract: When treating schizophrenia and other psychotic disorders, clinicians often encounter the problems of non-adherence, which is almost the most common drawback of achieving remission and a better quality of life. The uncertain oral drug taking habits may lead to relapses and rehospitalizations. Using second generation long acting injectables we have more possibilities to avoid these problems. This review attempts to present and describe the pharmacological background of the modern long acting injectables including patient cases where olanzapine pamoate long acting injectable provided remission and better quality of life for the patients.
authors.affiliation: Markusovszky Egyetemi Oktatókórház, Pszichiátriai Centrum, Szombathely, Hungary. sumegia@gmail.com
authors.forename: András
authors.initials: A
authors.lastname: Sümegi
authors.forename: János
authors.initials: J
authors.lastname: Kálmán
authors.forename: László
authors.initials: L
authors.lastname: Csekey
mesh_terms: D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007273:Injections, Intramuscular; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology*; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines; D000077152:Olanzapine